Lewis Roberts

Title: Lewis Roberts: Innovator in Pancreatobiliary Cancer Detection

Introduction

Lewis Roberts is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection and monitoring of pancreatobiliary cancer. His innovative approach has the potential to improve patient outcomes through early detection and assessment.

Latest Patents

Lewis Roberts holds a patent for "Materials and methods for diagnosis, prognosis, monitoring of recurrence, and assessment of therapeutic/prophylactic treatment of pancreatobiliary cancer." This patent describes a method for detecting high-grade dysplasia, pancreatobiliary cancer, or metastatic cancer to the pancreatobiliary tract. The method involves obtaining a sample of pancreatobiliary cells from a patient and using a set of detectably labeled probes for various genetic markers, including MCL1, EGFR, MYC, and P16. This innovative diagnostic tool aims to identify chromosomal abnormalities and assess the risk of cancer in patients.

Career Highlights

Throughout his career, Lewis Roberts has worked with prominent organizations such as Abbott Molecular Inc. and the Mayo Foundation for Medical Education and Research. His experience in these institutions has allowed him to develop and refine his diagnostic methods, contributing to advancements in cancer detection.

Collaborations

Lewis has collaborated with esteemed colleagues, including Irina A. Sokolova and Larry E. Morrison. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of medical diagnostics.

Conclusion

Lewis Roberts is a pioneering inventor whose work in pancreatobiliary cancer detection exemplifies the intersection of innovation and healthcare. His contributions have the potential to significantly impact patient care and improve diagnostic accuracy.